Selecta Biosciences (NASDAQ:SELB) Stock Rating Lowered by St

Selecta Biosciences (NASDAQ:SELB – Get Rating) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday. A number of other brokerages also recently issued reports on SELB. Zacks Investment Research upgraded shares of Selecta Biosciences from a “strong sell” rating to a […]

Related Keywords

Los Angeles , California , United States , Selecta Biosciences , Wells Fargo Company , Zacks Investment Research , Selecta Biosciences Company Profile Get Rating , Selecta Biosciences Inc , Los Angeles Capital Management , Asset Management , Invesco Ltd , Get Rating , Investment Research , Angeles Capital Management , Biosciences Company Profile , Synthetic Vaccine Particles , Nasdaq Selb , Selb , Medical , Downgrade , Stocknews Com ,